These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25516626)

  • 21. Role of caveolin and caveolae in insulin signaling and diabetes.
    Cohen AW; Combs TP; Scherer PE; Lisanti MP
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1151-60. PubMed ID: 14607781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.
    Kim JK; Zisman A; Fillmore JJ; Peroni OD; Kotani K; Perret P; Zong H; Dong J; Kahn CR; Kahn BB; Shulman GI
    J Clin Invest; 2001 Jul; 108(1):153-60. PubMed ID: 11435467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in glucose transporter expression and function in diabetes: mechanisms for insulin resistance.
    Kahn BB
    J Cell Biochem; 1992 Feb; 48(2):122-8. PubMed ID: 1618926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
    Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
    Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.
    Yore MM; Syed I; Moraes-Vieira PM; Zhang T; Herman MA; Homan EA; Patel RT; Lee J; Chen S; Peroni OD; Dhaneshwar AS; Hammarstedt A; Smith U; McGraw TE; Saghatelian A; Kahn BB
    Cell; 2014 Oct; 159(2):318-32. PubMed ID: 25303528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular biology as a tool in the study of glucose transport and metabolism.
    Foley JE; Bell PA
    Ann Med; 1990 Jun; 22(3):177-9. PubMed ID: 2393553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of glucose transport and GLUT4 transporter protein in type 2 diabetes mellitus.
    Davidson MB
    J Clin Endocrinol Metab; 1993 Jul; 77(1):25-6. PubMed ID: 8325949
    [No Abstract]   [Full Text] [Related]  

  • 28. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance.
    Gnudi L; Tozzo E; Shepherd PR; Bliss JL; Kahn BB
    Endocrinology; 1995 Mar; 136(3):995-1002. PubMed ID: 7867610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ChREBP in NASH - a liver transcription factor comes in from the cold.
    Charlton MR
    J Hepatol; 2013 Jul; 59(1):178-9. PubMed ID: 23523581
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).
    Gibbs EM; Stock JL; McCoid SC; Stukenbrok HA; Pessin JE; Stevenson RW; Milici AJ; McNeish JD
    J Clin Invest; 1995 Apr; 95(4):1512-8. PubMed ID: 7706456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An extended Myc network contributes to glucose homeostasis in cancer and diabetes.
    Peterson CW; Ayer DE
    Front Biosci (Landmark Ed); 2011 Jun; 16(6):2206-23. PubMed ID: 21622171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.
    Villanueva-Peñacarrillo ML; Puente J; Redondo A; Clemente F; Valverde I
    Endocrine; 2001 Jul; 15(2):241-8. PubMed ID: 11720253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.
    Laffitte BA; Chao LC; Li J; Walczak R; Hummasti S; Joseph SB; Castrillo A; Wilpitz DC; Mangelsdorf DJ; Collins JL; Saez E; Tontonoz P
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5419-24. PubMed ID: 12697904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of glucose transporter in muscle from insulin-resistant patients.
    Dohm GL; Elton CW; Friedman JE; Pilch PF; Pories WJ; Atkinson SM; Caro JF
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E459-63. PubMed ID: 2003599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms of improvement of insulin resistance by exercise treatment].
    Yamanouchi K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():261-6. PubMed ID: 12387003
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin stimulates the halting, tethering, and fusion of mobile GLUT4 vesicles in rat adipose cells.
    Lizunov VA; Matsumoto H; Zimmerberg J; Cushman SW; Frolov VA
    J Cell Biol; 2005 May; 169(3):481-9. PubMed ID: 15866888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking.
    Maianu L; Keller SR; Garvey WT
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5450-6. PubMed ID: 11701721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
    Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic Flexibility in Health and Disease.
    Goodpaster BH; Sparks LM
    Cell Metab; 2017 May; 25(5):1027-1036. PubMed ID: 28467922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin action in adipocytes, adipose remodeling, and systemic effects.
    Santoro A; McGraw TE; Kahn BB
    Cell Metab; 2021 Apr; 33(4):748-757. PubMed ID: 33826917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.